Emergent BioSolutions
EBS
#7590
Rank
โ‚ฌ0.35 B
Marketcap
6,83ย โ‚ฌ
Share price
-3.29%
Change (1 day)
15.02%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): โ‚ฌ0.14 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are โ‚ฌ0.75 Billion. In 2024 the company made an earning of -โ‚ฌ61.82 Million, an increase over its 2023 earnings that were of -โ‚ฌ0.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.14 B-338.15%
2024 -โ‚ฌ61.82 Million-88.82%
2023 -โ‚ฌ0.56 Billion242.73%
2022 -โ‚ฌ0.17 Billion-153.8%
2021 โ‚ฌ0.29 B-20.43%
2020 โ‚ฌ0.37 B278.02%
2019 โ‚ฌ99.73 M27.11%
2018 โ‚ฌ78.46 M-27.12%
2017 โ‚ฌ0.10 B17.21%
2016 โ‚ฌ91.85 M0.45%
2015 โ‚ฌ91.45 M73.51%
2014 โ‚ฌ52.7 M41.36%
2013 โ‚ฌ37.28 M35.2%
2012 โ‚ฌ27.57 M0.4%
2011 โ‚ฌ27.46 M-56.46%
2010 โ‚ฌ63.08 M76.73%
2009 โ‚ฌ35.69 M32.94%
2008 โ‚ฌ26.85 M-5.62%
2007 โ‚ฌ28.45 M
2005 โ‚ฌ41.19 M269.89%
2004 โ‚ฌ11.13 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ9.10 B 6,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ11.30 B 7,856.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ8.60 B 5,956.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-โ‚ฌ10.64 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚ฌ77.62 M-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.25 Billion-273.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.95 B 1,273.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel